Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Apr 1612:00 PM EDT
-11:59 PM EDT
You’re first to know: Save $200 on GMAT prep starting tomorrow, 4/13. Get 6 official practice tests and study with real questions. Be ready to save!
Apr 2212:30 AM EDT
-01:30 AM EDT
At one point, she believed GMAT wasn’t for her. After scoring 595, self-doubt crept in and she questioned her potential. But instead of quitting, she made the right strategic changes. The result? A remarkable comeback to 695. Check out how Saakshi did it.
Apr 2301:30 AM EDT
-02:30 AM EDT
Struggling with GMAT Verbal as a non-native speaker? Harsh improved his score from 595 to 695 in just 45 days—and scored a 99 %ile in Verbal (V88)! Learn how smart strategy, clarity, and guided prep helped him gain 100 points.
Apr 2308:00 PM PDT
-09:00 PM PDT
Video explanations + diagnosis of 10 weakest areas + 150+ short videos + study plan!
Apr 2610:00 AM EDT
-11:00 AM EDT
The Target Test Prep course represents a quantum leap forward in GMAT preparation, a radical reinterpretation of the way that students should study. Try before you buy with a 5-day, full-access trial of the course for FREE!
Apr 2711:00 AM EDT
-12:00 PM EDT
Prefer video-based learning? The Target Test Prep OnDemand course is a one-of-a-kind video masterclass featuring 400 hours of lecture-style teaching by Scott Woodbury-Stewart, founder of Target Test Prep and one of the most accomplished GMAT instructors
Apr 2808:00 AM PDT
-11:00 AM PDT
Whether you are just beginning your MBA journey or fine-tuning your path to a 700+ score, GMAT Day is designed to give you a competitive edge.
28 Jul 2021, 04:00
Kudos
Bookmarks
E
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
15%
(low)
Question Stats:
80% (01:51) correct
20%
(02:04)
wrong
based on 415
sessions
History
Date
Time
Result
Not Attempted Yet
A pharmaceutical company has come under public scrutiny for manufacturing a controversial drug. Tests indicate that the drug provides the advertised results, but there are potentially serious side effects that clearly outweigh the positive results. After extensive further testing, the CEO of the pharmaceutical company has announced that the drug is now safe: “With the approval of the FDA, our new drug may now be marketed and sold tohospitals around the country to respond to a serious medical problem that doctors have been unable to address effectively before now.”
Which of the following, if true, most seriously calls into question the pharmaceutical company’s claim that their drug is now safe?
(A) Records indicate that the pharmaceutical company has lied in the past about the safety of controversial drugs that it has manufactured.
(B) The pharmaceutical company is receiving a large government grant to enable its improvement of the drug.
(C) The board of the pharmaceutical company is currently under federal investigation for charges of marketing fraud.
(D) A competitor pharmaceutical company is in the process of manufacturing a drug that will offer similar results but without the side effects.
(E) The FDA approval required the altering of certain ingredients within the controversial drug, and there is no evidence that the company made the changes.
Which of the following, if true, most seriously calls into question the pharmaceutical company’s claim that their drug is now safe?
(A) Records indicate that the pharmaceutical company has lied in the past about the safety of controversial drugs that it has manufactured.
(B) The pharmaceutical company is receiving a large government grant to enable its improvement of the drug.
(C) The board of the pharmaceutical company is currently under federal investigation for charges of marketing fraud.
(D) A competitor pharmaceutical company is in the process of manufacturing a drug that will offer similar results but without the side effects.
(E) The FDA approval required the altering of certain ingredients within the controversial drug, and there is no evidence that the company made the changes.
31 Jul 2021, 04:00
Kudos
Bookmarks
Bunuel
OFFICIAL EXPLANATION
Overview:
In this question, the student is given information about a pharmaceutical company that has manufactured a controversial drug and is attempting to market it. The studies that have been done on the drug indicate that it does offer the results claimed but that it also creates serious side effects. After more testing, the CEO of the pharmaceutical company makes a statement that the drug is safe and will be marketed and sold with the approval of the FDA. The question asks the student to select the answer choice that most seriously undermines the statements made by the CEO of the pharmaceutical company. Each answer choice will have to be considered individually, but there are several points within the passage on which the student needs to focus: (1) the drug is controversial and has potentially serious side effects, (2) the pharmaceutical company has done further testing, and (3) the CEO does not actually claim that the FDA has approved the drug but that it will be marketed and sold “with the approval of the FDA.” This final point might be the most significant, since the CEO’s wording is suspiciously confusing—“with the approval of the FDA” suggests a conditional approval that could affect the safety of the drug and the ability of the pharmaceutical company to market it legally.
The Correct Answer:
E As suggested in the Overview above, answer choice (E) offers a statement that indicates a conditional approval from the FDA. This approval is based on the altering of ingredients in the drug, and there is nothing to indicate that the company has altered the ingredients. So the drug would probably not be safe, and the CEO is making claims that seem to be deliberately obscure. Answer choice (E) is correct.
The Incorrect Answers:
A Although previous behavior may indicate future actions, there is no guarantee that just because the company has lied in the past it is lying again. Answer choice (A) offers far too tenuous a reason to undermine the CEO’s claims, so it is not correct.
B The presence of government money is largely irrelevant to the accuracy of the CEO’s claims in this case. Furthermore, if the company were receiving government money, it is more likely that they would be willing to make the drug as safe as possible since someone else would be paying the bill, and the company would be required to submit to yet another level of government oversight. Answer choice (B) actually functions more in support of the CEO’s claims, so it is not correct.
C As in answer choice (A), the fact that the board of the pharmaceutical company is being investigated for marketing fraud does not necessarily mean that they are committing marketing fraud in this case. The connection between the two events is too uncertain to be valid, so answer choice (C) is incorrect.
D The fact that another pharmaceutical company is in the process of manufacturing a similar drug does more to support the CEO’s claims than to undermine them, because the original pharmaceutical company would be more likely to produce a safe drug with a competitor on the market. Answer choice (D) is also incorrect.
General Discussion
